Replies to post #113186 on Biotech Values

[RockRat]

See subsequent posts, but it was the immunogenicity data, which, according to the FDA, was requested to assess the manufacturing process wrt impurities. We know that was not a "minor" slowdown, timewise.

Regards, RockRat